Benjamin Edwards’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.97M Sell
15,395
-6,427
-29% -$794K 0.03% 474
2026
Q2
$2.24M Sell
21,822
-4,956
-19% -$322K 0.02% 543
2026
Q1
$1.27M Sell
26,778
-2,854
-10% -$128K 0.01% 674
2025
Q4
$940K Buy
29,632
+1,309
+5% +$40.8K 0.01% 735
2025
Q3
$797K Buy
28,323
+4,410
+18% +$134K 0.01% 772
2025
Q2
$880K Buy
23,913
+2,343
+11% +$81K 0.01% 671
2025
Q1
$847K Buy
21,570
+3,864
+22% +$174K 0.01% 627
2024
Q4
$823K Buy
17,706
+5,033
+40% +$227K 0.01% 675
2024
Q3
$572K Buy
12,673
+12,549
+10,120% +$597K 0.01% 756
2024
Q2
$6K Sell
124
-72
-37% -$2.94K ﹤0.01% 640
2024
Q1
$7K Buy
196
+52
+36% +$1.88K ﹤0.01% 661
2023
Q4
$5K Sell
144
-108
-43% -$2.5K ﹤0.01% 610
2023
Q3
$5K Hold
252
– – ﹤0.01% 601
2023
Q2
$5K Buy
252
+58
+30% +$869 ﹤0.01% 613
2023
Q1
$3K Buy
194
+152
+362% +$3.36K ﹤0.01% 652
2022
Q4
$1K Buy
+42
New +$1.22K ﹤0.01% 710

Other funds holding TWST

Benjamin Edwards's TWST Position: Q3 2026 in Review

Benjamin Edwards reduced its Twist Bioscience (TWST) stake by 29% in Q3 2026, selling an estimated $794K and leaving 15,395 shares worth $2.97M. The position accounts for 0.03% of the portfolio, ranked #474.

Benjamin Edwards first reported a position in TWST in Q4 2022 and has held it in 16 quarters since. 330 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Benjamin Edwards held 15,395 shares of Twist Bioscience worth $2.97M as of Q3 2026.
  • Benjamin Edwards sold 6,427 Twist Bioscience shares in Q3 2026, an estimated $794K.
  • Twist Bioscience made up 0.03% of Benjamin Edwards's portfolio in Q3 2026, its #474 holding.
  • Benjamin Edwards first reported a position in Twist Bioscience in Q4 2022 and has held it in 16 quarters since.
  • 330 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.